Medifast (MED) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $14.2 million.
- Medifast's Accumulated Depreciation & Amortization rose 1208.0% to $14.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $14.2 million, marking a year-over-year increase of 1208.0%. This contributed to the annual value of $14.2 million for FY2025, which is 1208.0% up from last year.
- Medifast's Accumulated Depreciation & Amortization amounted to $14.2 million in Q4 2025, which was up 1208.0% from $12.7 million recorded in Q4 2024.
- Over the past 5 years, Medifast's Accumulated Depreciation & Amortization peaked at $14.2 million during Q4 2025, and registered a low of $6.8 million during Q4 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $11.6 million, with a median of $12.7 million in 2024.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 6118.61% in 2022, then plummeted by 305.18% in 2024.
- Quarter analysis of 5 years shows Medifast's Accumulated Depreciation & Amortization stood at $6.8 million in 2021, then soared by 61.19% to $11.0 million in 2022, then grew by 19.37% to $13.1 million in 2023, then dropped by 3.05% to $12.7 million in 2024, then rose by 12.08% to $14.2 million in 2025.
- Its Accumulated Depreciation & Amortization was $14.2 million in Q4 2025, compared to $12.7 million in Q4 2024 and $13.1 million in Q4 2023.